Barrett Elizabeth A.
- SEC CIK
- 0001764157
No open-market purchases or sales filed in the past year.
Current role at each company
- ALLO Allogene Therapeutics, Inc.Directoras of Jun 23, 2026
- URGN UroGen Pharma Ltd.Chief Executive Officeras of Feb 19, 2026
- SAGE Sage Therapeutics, Inc.Directoras of Jul 31, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Barrett Elizabeth A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
URGN UroGen Pharma Ltd.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 (view filing) | Jan 31 | 2 days | Barrett Elizabeth A.Chief Executive Officer | SSale | −8.20K | $7.58 | −$62.1K | −2.6%308.4K after | 2 lots |
| Jan 7, 2022 (view filing) | Jan 4 | 3 daysLate | Barrett Elizabeth A.Chief Executive Officer | SSale | −47.0K | $9.15 | −$429.8K | −13.6%298.2K after |